Penumbra Revenue 2014-2024 | PEN

Penumbra annual/quarterly revenue history and growth rate from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Penumbra revenue for the quarter ending June 30, 2024 was $0.299B, a 14.49% increase year-over-year.
  • Penumbra revenue for the twelve months ending June 30, 2024 was $1.134B, a 20.89% increase year-over-year.
  • Penumbra annual revenue for 2023 was $1.059B, a 24.95% increase from 2022.
  • Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
  • Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
Penumbra Annual Revenue
(Millions of US $)
2023 $1,059
2022 $847
2021 $748
2020 $560
2019 $547
2018 $445
2017 $334
2016 $263
2015 $186
2014 $126
2013 $89
Penumbra Quarterly Revenue
(Millions of US $)
2024-06-30 $299
2024-03-31 $279
2023-12-31 $285
2023-09-30 $271
2023-06-30 $261
2023-03-31 $241
2022-12-31 $221
2022-09-30 $214
2022-06-30 $208
2022-03-31 $204
2021-12-31 $204
2021-09-30 $190
2021-06-30 $184
2021-03-31 $169
2020-12-31 $167
2020-09-30 $151
2020-06-30 $105
2020-03-31 $137
2019-12-31 $145
2019-09-30 $140
2019-06-30 $134
2019-03-31 $128
2018-12-31 $121
2018-09-30 $112
2018-06-30 $110
2018-03-31 $103
2017-12-31 $96
2017-09-30 $84
2017-06-30 $81
2017-03-31 $73
2016-12-31 $73
2016-09-30 $67
2016-06-30 $65
2016-03-31 $58
2015-12-31 $54
2015-09-30 $50
2015-06-30 $42
2015-03-31 $39
2014-12-31
2014-09-30 $32
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.893B $1.059B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.021B 27.33
Intuitive Surgical (ISRG) United States $172.269B 97.54
Alcon (ALC) Switzerland $47.692B 33.57
IQVIA Holdings (IQV) United States $41.794B 23.68
Edwards Lifesciences (EW) United States $41.042B 26.31
IDEXX Laboratories (IDXX) United States $39.200B 47.16
DexCom (DXCM) United States $27.734B 39.55
STERIS (STE) Ireland $22.376B 26.11
SONOVA HOLDING (SONVY) Switzerland $22.049B 0.00
Waters (WAT) United States $21.250B 31.68
Hologic (HOLX) United States $18.538B 20.15
Sysmex ADR (SSMXY) Japan $12.254B 38.43
Fresenius Medical Care AG KGaA (FMS) Germany $11.502B 12.89
Teleflex (TFX) United States $11.121B 17.29
Globus Medical (GMED) United States $9.556B 26.73
Masimo (MASI) United States $7.481B 40.06
Glaukos (GKOS) United States $6.973B 0.00
TransMedics (TMDX) United States $4.510B 193.13
Integer Holdings (ITGR) United States $4.334B 25.34
PROCEPT BioRobotics (PRCT) United States $3.724B 0.00
LivaNova (LIVN) United Kingdom $2.852B 16.73
Veracyte (VCYT) United States $2.613B 162.00
Elekta AB (EKTAY) Sweden $2.595B 21.14
Inari Medical (NARI) United States $2.436B 0.00
Tandem Diabetes Care (TNDM) United States $2.427B 0.00
Nihon Kohden (NHNKY) Japan $2.246B 13.98
RxSight (RXST) United States $1.857B 0.00
Integra LifeSciences Holdings (IART) United States $1.492B 6.80
Artivion (AORT) United States $1.086B 99.69
Pulse Biosciences (PLSE) United States $1.047B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.037B 18.50
OPKO Health (OPK) United States $1.018B 0.00
Alphatec Holdings (ATEC) United States $0.723B 0.00
Mesa Laboratories (MLAB) United States $0.683B 17.24
AxoGen (AXGN) United States $0.645B 0.00
IRadimed (IRMD) United States $0.639B 34.53
OrthoPediatrics (KIDS) United States $0.596B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.595B 0.00
SiBone (SIBN) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.540B 0.00
Paragon 28 (FNA) United States $0.478B 0.00
Tactile Systems Technology (TCMD) United States $0.336B 10.26
Treace Medical Concepts (TMCI) United States $0.327B 0.00
ClearPoint Neuro (CLPT) United States $0.320B 0.00
Sight Sciences (SGHT) United States $0.289B 0.00
AngioDynamics (ANGO) United States $0.260B 0.00
Delcath Systems (DCTH) United States $0.231B 0.00
Inogen (INGN) United States $0.213B 0.00
NeuroPace (NPCE) United States $0.193B 0.00
Semler Scientific (SMLR) United States $0.192B 13.46
Accuray (ARAY) United States $0.184B 0.00
Atossa Genetics (ATOS) United States $0.181B 0.00
Nevro (NVRO) United States $0.180B 0.00
CVRx (CVRX) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.153B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
908 Devices (MASS) United States $0.120B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.109B 16.15
EDAP TMS S.A (EDAP) France $0.097B 0.00
WORK Medical Technology Group (WOK) China $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
InspireMD (NSPR) Israel $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.063B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Lucid Diagnostics (LUCD) United States $0.042B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.038B 0.00
Vicarious Surgical (RBOT) United States $0.038B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Neuronetics (STIM) United States $0.028B 0.00
Precision Optics (POCI) United States $0.027B 0.00
T2 Biosystems (TTOO) United States $0.026B 0.00
Pixie Dust Technologies (PXDT) Japan $0.025B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.014B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00